Fetal Human Keratinocytes Produce Large Amounts of Antimicrobial Peptides: Involvement of Histone-Methylation Processes  by Gschwandtner, Maria et al.
Fetal Human Keratinocytes Produce Large Amounts
of Antimicrobial Peptides: Involvement of
Histone-Methylation Processes
Maria Gschwandtner1,4, Shaomin Zhong1,2,4, Antonia Tschachler1, Veronika Mlitz1, Susanne Karner1,
Adelheid Elbe-Bu¨rger3 and Michael Mildner1
Antimicrobial peptides (AMPs), an important part of the innate immune system, are crucial for defense against
invading microorganisms. Whereas AMPs have been extensively studied in adult skin, little is known about the
impact of AMPs in the developing human skin. We therefore compared the expression and regulation of AMPs in
fetal, neonatal, and adult keratinocytes (KCs) in vitro. The constitutive expression of human b-defensin-2 (HBD-2),
HBD-3, S100 protein family members, and cathelicidin was significantly higher in KCs from fetal skin than in KCs
from postnatal skin. The capacity to further increase AMP production was comparable between prenatal and
postnatal KCs. Analysis of skin equivalents (SEs) revealed a strong constitutive expression of S100 proteins in fetal
but not in neonatal and adult SEs. The elevated AMP levels correlated with reduced H3K27me3 (tri-methyl-lysine
27 on histone H3) levels and increased expression of the histone demethylase JMJD3. Knockdown of JMJD3 in
fetal KCs elevated H3K27me3 levels and significantly downregulated the expression of HBD-3, S100A7, S100A8,
S100A9, and cathelicidin. Our data indicate a crucial contribution of histone modifications in the regulation of
AMP expression in the skin during ontogeny. The elevated AMP expression in prenatal skin might represent an
essential defense strategy of the unborn.
Journal of Investigative Dermatology (2014) 134, 2192–2201; doi:10.1038/jid.2014.165; published online 8 May 2014
INTRODUCTION
Antimicrobial peptides (AMPs) are a diverse group of mostly
cationic polypeptides with antimicrobial cytotoxic activities
against bacteria, fungi, and viruses. The mode of action of
AMPs against bacteria include the formation of transmem-
brane pores, as well as metabolic interference (Brogden,
2005). The main groups of AMPs identified so far in adult
human skin include defensins, cathelicidins, and members of
the RNase and the S100 families (Harder and Schro¨der, 2005;
Schro¨der and Harder, 2006). Whereas some AMPs, such as
RNase 7 and S100 proteins, are constitutively expressed in the
upper layers of the epidermis, others such as human
b-defensin-2 (HBD-2) and HBD-3 are inducible in response
to pathogen invasion of the skin or by inflammatory mediators
(Harder and Schro¨der, 2002, 2005; Schro¨der and Harder,
2006; Suter et al., 2009; Afshar and Gallo, 2013). In addition
to their direct antimicrobial effect, AMPs also have important
immunomodulatory properties (Yang et al., 2001b, 2002,
2004). Although b-defensins are chemotactic for dendritic
cells and memory T cells by binding to CCR6 (Yang et al.,
2002), cathelicidins are chemotactic for neutrophils,
monocytes, and T cells but not for dendritic cells (Yang
et al., 2001a). In addition, AMPs not only attract immune
cells but are also able to activate them directly. S100A7, for
example, has been shown to induce secretion of cytokines and
chemokines from neutrophils, which in turn contribute to
innate immunity through enhancing neutrophil host defense
functions (Zheng et al., 2008).
Recent studies showed that histone modifications, espe-
cially lysine methylation, have an important function during
cell differentiation and organ development. In particular, the
methylation status of histone H3K27 has been associated with
the activation and repression of a variety of developmental
genes (Nottke et al., 2009). In addition, Sen et al. (2008)
identified an important role of H3K27 trimethylation in
epidermal cells during epidermal differentiation. KCs lacking
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JMJD3 expression, the enzyme responsible for demethylation
of H3K27, showed an impaired KC differentiation process,
resulting in reduced levels of KC differentiation–associated
proteins such as certain keratins, involucrin, and S100A8.
Accordingly, depletion of EZH2, a histone methyltransferase
trimethylating H3K27, resulted in premature epidermal
differentiation (Sen et al., 2008). The importance of H3K27,
JMJD3, and EZH2 has also been demonstrated in tissue
regeneration and wound healing (Shaw and Martin, 2009;
Ezhkova et al., 2011).
In contrast to adult human skin, only few data have been
published on AMP expression and regulation in developing
prenatal human skin. Cathelicidin, human neutrophil
defensins, and S100A7 have been detected in vernix caseosa
and full-term amniotic fluid (Marchini et al., 2002; Yoshio
et al., 2003; Porre et al., 2005), and RNAse 7 and S100A7
have been found to be present in fetal human epidermis
(Schuster et al., 2013), indicating that AMPs have a role in
prenatal antimicrobial defense. Furthermore, systematic studies
on the human skin innate immune system during prenatal
development have recently demonstrated that prenatal skin
expresses the same spectrum of pattern recognition receptors
as adult skin and that Toll-like receptors (TLRs) 1–5, NODs 1/2,
NALPs 1/3, and DECTIN-1 are even significantly higher
expressed in prenatal than in postnatal skin. Functional
experiments revealed that fetal human KCs strongly react to
the activation of TLRs, suggesting an enhanced innate immune
response of prenatal skin (Iram et al., 2012). Taken together,
these data demonstrated that fetal KCs are equipped with
specific immune functions to combat invading pathogens.
Once born, the neonate is exposed to an abundance of
microbial agents. As the neonatal immune system is not yet
fully responsive (Chorro and Geissmann, 2010; Elbe-Bu¨rger
and Schuster, 2010; Ginhoux and Merad, 2010; PrabhuDas
et al., 2011; Palin et al., 2013), innate immunity presumably
has a crucial role for protection of the newborn against
invading pathogens. To further explore the role of AMPs as
a rapid first line of defense in the developing human skin, we
investigated the expression profile of several groups of AMPs
in prenatal and postnatal KCs.
RESULTS
Fetal KCs express high levels of mRNA from antimicrobial
peptides
To assess comparatively the expression pattern of several
AMPs in proliferating and differentiated prenatal and postnatal
KCs, we performed real-time PCR for HBD-1, HBD-2, HBD-3,
S100A7, S100A8, S100A9, RNase5, RNase7, and cathelicidin.
As shown in Figure 1, mRNA levels of HBD-2, HBD-3,
S100A7, S100A8, S100A9, and cathelicidin were significantly
higher in KCs from several fetal donors as compared with KCs
derived from skin of neonatal and adult donors in proliferating
(Figure 1a) and differentiated KCs (Figure 1b). In contrast to
postnatal KC expression, the level of HBD-1 was only weakly
inducible by differentiation of fetal KCs. S100A8 and RNase5
were not inducible at all in neonatal KCs (Table 1). Differ-
ences between the AMP expression levels of proliferating
neonatal and adult KCs were not detected (Figure 1a), whereas
in differentiated KCs the expression of HBD-2, S100A7, and
S100A8 was constantly higher than in adult KCs (Figure 1b).
Regulation of the KC differentiation–dependent proteins
keratin 14, keratin 10, filaggrin, and loricrin was comparable
in all three KC groups before and after induction of KC differ-
entiation (Supplementary Figure S1 online), suggesting a
comparable differentiation process in prenatal and postnatal
KCs. These data demonstrate that despite comparable capa-
cities of KCs derived from different age groups to proliferate
and differentiate, fetal KCs constitutively express significantly
higher levels of HBD-2, HBD-3, S100A7, S100A8, S100A9
(only in differentiated KCs), and cathelicidin than adult and
neonatal KCs.
Fetal KCs constitutively produce high levels of HBD-2 and S100
proteins
We next analyzed the production of AMP proteins by ELISA
and western blot analysis. As HBD-2 belongs to a group of
inducible AMPs, we also included IL-1a and the TLR5L
flagellin, two known inducers of HBD-2 expression in
postnatal KCs (Abtin et al., 2008), as stimulants. In line
with our real-time PCR data, significantly higher levels of
HBD-2 protein were detected in cell lysates of nonstimulated
fetal KCs (2,204±490 pg ml1) than in neonatal (754±
35 pg ml1) and adult (232±8 pg ml 1) KCs (Figure 2a).
The capacity of IL-1a and flagellin to upregulate HBD-2 was
largely comparable in lysates of prenatal and postnatal cells
(Figure 2a). Surprisingly, considerable amounts (224±
92 pg ml1) of HBD-2 were already released by unstimulated
fetal KCs but were not detectable in neonatal KCs and only
barely detectable in adult KCs (Figure 2b). Both IL-1a and
flagellin induced the strong release of HBD-2 in fetal KCs
(1,237±349and 850±256 pg ml 1) (Figure 2b), but induction
was much less pronounced in neonatal (193±21 and
409±76 pg ml1) and adult (76±57 and 243±73 pg ml1)
KCs (Figure 2b).
Our mRNA results on S100A7-9 were corroborated by
studying the production of S100 proteins. As shown in
Figure 3, western blot analysis revealed strong baseline
expression of S100A7, S100A8, and S100A9 in fetal prolifer-
ating KCs, whereas their expression was marginal in neonatal
and adult KCs (Figure 3a). As mRNA expression of the S100
proteins was induced in differentiated KCs (Table 1), we also
established SE cultures from KCs of different age groups and
analyzed their protein production by western blot analysis
(Figure 3b) and immunofluorescence staining (Figure 3c). As
in monolayer cultures, the expression of all three S100
proteins was significantly higher in SEs established with fetal
than with neonatal and adult KCs (Figure 3b). This observation
was confirmed by immunostaining of SEs. All three S100
proteins were strongly present throughout all epidermal layers
in SE cultures of fetal KCs. Whereas in SE cultures of neonatal
and adult KCs only the expression pattern of S100A8 was
comparable with the one in fetal SEs, S100A7 and S100A9
were only focally expressed (Figure 3c). Although cathelicidin
mRNA was present in all KCs tested, we could not detect the
protein expression of cathelicidin in monolayer cultures and
SEs using ELISA (data not shown).
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TLR activation differently regulates the expression of HBD-2,
S100A7, and S100A8 mRNA in prenatal and postnatal KCs
To investigate the regulation of AMPs after TLR signaling in
prenatal and postnatal KCs, proliferating cells were stimulated
with the TLR ligands (TLRLs) 1–9 and analyzed by real-time
PCR. A regulation was only observed for HBD-2, HBD-3, and
the S100 proteins (Table 2, gray) but not for HBD-1, RNase5
and 7, as well as cathelicidin independent of KC source and
TLRL (Table 2). S100A8 showed the strongest response to
cytokine and TLR activation in fetal KCs, whereas HBD-2 and
S100A7 were most potently induced in postnatal KCs.
Regulation of S100A9 was comparable between prenatal and
postnatal KCs. HBD-3 was only weakly induced in fetal and
neonatal KCs after TLR-3 activation. IL-1a served as a positive
control and upregulated HBD-2 and the S100 proteins in fetal
and adult KCs, and slightly upregulated HBD-3 in fetal KCs. The
TLRL poly(I:C) (TLR3L), flagellin (TLR5L), and FSL1 (TLR6L) most
potently upregulated AMP expression (Table 2, highlighted in
gray). However, the total amount of HBD-2 mRNA was still
slightly higher and the total amount of S100A7 and S100A8
mRNA was more than 100-fold higher in fetal KCs compared
with neonatal and adult KCs (Supplementary Figure S2 online).
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Figure 1. Fetal keratinocytes (KCs) have a different antimicrobial peptide (AMP) mRNA expression pattern when compared with neonatal and adult KCs.
Fetal, neonatal, and adult KCs cultured under proliferating and differentiated conditions were investigated for AMP expression levels using quantitative real-time
PCR. (a) Proliferating fetal KCs expressed significantly higher levels of human b-defensin-2 (HBD-2), HBD-3, S100A7, S100A8, and cathelicidin as compared with
neonatal and adult KCs. (b) Differentiated fetal KCs expressed significantly higher levels of HBD-2, S100A7, S100A8, S100A9, and cathelicidin as compared
with neonatal and adult KCs. The median and individual data points of (a) six to nine different donors from each age group and (b) four donors from each age group
are shown. Each data point represents the mean of a measurement with three replicates; Mann–Whitney test, *Po0.05, **Po0.005; CP value: mean PCR
crossing point of all proliferating KC samples (for comparison: the CP of the housekeeping gene b2-microglobulin (b2M) was 19.3±1.1).
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Expression of the histone demethylase JMJD3 influences the
expression of HBD-3, S100A7, S100A8, S100A9, and
cathelicidin
The histone demethylase JMJD3 and histone methyltrans-
ferase EZH2 are involved in gene regulation during KC
differentiation by erasing and adding trimethyl groups to
H3K27 present at diverse promoters including the S100A8
promoter (Sen et al., 2008). We therefore investigated the
expression of JMJD3 and EZH2 mRNA in fetal, neonatal,
and adult KCs. We found that JMJD3 expression was
significantly higher in proliferating fetal KCs as compared
with both neonatal and adult KCs (Figure 4a). Moreover, KC
differentiation in monolayer cultures additionally increased
JMJD3 expression in fetal cells, whereas no significant
increase was observed with neonatal and adult KCs
(Figure 4b). In contrast, EZH2 expression was comparable in
prenatal and postnatal KCs and was not regulated during KC
differentiation in monolayer cultures (Figure 4c and d).
Western blot analysis revealed that, in contrast to postnatal
KCs, H3K27me3 (tri-methyl-lysine 27 on histone H3)
was barely detectable in fetal KCs (Figure 4e). Spearman’s
correlation between JMJD3 and the AMPs tested in our
study showed a high correlation for HBD-3 (R¼0.861),
S100A7 (R¼0.758), S100A8 (R¼ 0.585), and cathelicidin
(R¼0.698) (Supplementary Figure S3 online). To further
investigate the contribution of JMJD3 to AMP expression, we
next performed JMJD3 knockdown experiments using
small interfering RNA (siRNA) technology. Knockdown of
JMJD3 in fetal KCs led to significantly reduced expression
levels of HBD-3, all S100 proteins tested, and cathelicidin
(Figure 4f). In addition, H3K27me3 was increased in JMJD3
knockout cells (Figure 4g).
DISCUSSION
The innate component of the skin immune system is the first
line of defense, protecting the body from invasion of microbial
pathogens. This first line consists of the physical barrier of the
stratum corneum and the presence or induction of AMPs
produced by epithelial cells (Wiesner and Vilcinskas, 2010;
Afshar and Gallo, 2013). Under physiological conditions,
these mechanisms prevent microbial invasion on exposed
body sites such as the skin but also colonization of sterile body
sites such as the cerebrospinal fluid and the amniotic cavity by
pathogenic microbes. Because of the fact that the adaptive
immune system is not yet fully functional in utero (Chorro and
Geissmann, 2010; Elbe-Bu¨rger and Schuster, 2010; Ginhoux
and Merad, 2010; PrabhuDas et al., 2011; Palin et al., 2013;
Schuster et al., 2012), the innate immune system, especially
AMPs and pattern recognition receptors, has been suggested to
have central roles for the survival of the developing fetus and
the newborns (Dorschner et al., 2003; Iram et al., 2012). In the
present study, we have investigated the expression and
regulation of a variety of AMPs in KCs derived from fetal,
neonatal, and adult skin.
The sterility of the amniotic cavity is thought to be
established and maintained by the action of multiple physical
and chemical barriers such as the vaginal (Mildner et al.,
2010b) and cervical epithelium (Svinarich et al., 1997), the
cervical mucus plug (Hein et al., 2002), and the chorioamnio-
tic membranes (Kjaergaard et al., 2001). Although these
epithelia and membranes represent a powerful defense
against invading pathogens, some are still able to cross these
barriers (Evaldson et al., 1983; Galask et al., 1984). Although
Table 1. Induction of AMPs in differentiated KCs
Gene Fet. Neo. Ad.
HBD-1 2 14* 7*
HBD-2 8* 5* 7*
HBD-3 2 5* 8*
S100A7 3* 2* 7*
S100A8 6* 1 6*
S100A9 5* 2* 4*
RNase5 2 1 3*
RNase7 2* 18* 7*
Cathelicidin 7* 5* 8*
JMJD3 5* 1 1
Abbreviations: Ad., adult; AMP, antimicrobial peptide; Fet., fetal; Neo.,
neonatal; HBD, human b-defensin; KC, keratinocyte.
Fold induction of AMPs in differentiated Fet., Neo., and Ad. KCs compared
with proliferating KCs is shown. Statistically significant values are high-
lighted in gray. The mean fold induction was calculated from four
independent donors of each age group, each performed in triplicate, and
statistical significance was calculated with Wilcoxon’s signed-rank test:
*Po0.05.
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Figure 2. Human b-defensin-2 (HBD-2) expression and secretion is increased
in fetal keratinocytes (KCs). Fetal, neonatal, and adult KCs were cultured for
24 hours in the presence or absence of IL-1a or the TLR5L flagellin, and the
concentration of HBD-2 in (a) cell lysates and (b) supernatants was determined
by ELISA. Basal HBD-2 levels (NS) were significantly higher in supernatants
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NS, nonstimulated control; TLR, Toll-like receptor.
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Figure 3. Fetal keratinocytes (KCs) express high levels of S100A7, S100A8, and S100A9 protein in monolayer and skin equivalent (SE) cultures. Fetal, neonatal,
and adult KCs were cultured under proliferating conditions in monolayer cultures and analyzed for the expression of S100 proteins (a). Western blot analysis
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SEs from fetal, neonatal, and adult KCs were established and analyzed by (b) western blot analysis and (c) immunfluorescence staining. Western blot analysis
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it is well established that amniotic fluids have strong anti-
microbial activity and contain several AMPs including
human neutrophil peptides 1–3, bactericidal/permeability-
increasing protein, S100A7 (Porre et al., 2005), and S100A8/
A9 (Sampson et al., 1997; Espinoza et al., 2003), our
knowledge of AMP expression in fetal skin is scarce. The
facts that (i) KCs are a rich source of AMPs, (ii) S100A7 is
primarily of epithelial origin, (iii) AMPs of the cathelicidin and
b-defensin families are present in human newborn foreskin
specimens (Dorschner et al., 2003), and (iv) RNase7 is
expressed in the periderm and prenatal epidermis (Schuster
et al., 2013) prompted us to investigate the contribution of
fetal KCs to the innate immune defense of the fetus. We found
that already under normal culture conditions fetal KCs
produce significantly more HBD-2, HBD-3, S100A7-9, and
cathelicidin than either neonatal or adult KCs. Our finding was
surprising, as Schuster et al. (2013) did not find increased
HBD-2 and S100A7 expression levels in fetal skin. Possible
explanations for this discrepancy could be a different
experimental design of the two groups. In contrast to our
work, Schuster et al. (2013) investigated supernatants from cell
suspensions derived from full-thickness skin samples (dermis
and epidermis), thus probably having a dilution effect. In
addition, they cultured their cells in a medium that was not
favorable for the survival and growth of KCs. As to the
differences seen in their in vivo staining, it is tempting to
speculate that the aqueous environment in which the fetus is
embedded together with the not yet fully established cornified
layer of the epidermis favors a more rapid release of soluble
factors, resulting in a weaker staining intensity. Also striking
was the fact that fetal KCs constitutively express much higher
levels of AMPs than neonatal KCs, suggesting that the elevated
levels described in newborn skin specimens (Dorschner et al.,
2003) may be due to the exposure to the new environment.
The fact that the high constitutive production of AMPs was
maintained even after several passages under sterile
conditions and in the presence of antibiotics excludes the
possibility that bacterial contamination accounts for activation
of fetal KCs in our cultures. It rather indicates that AMP
production is due to cell-autonomous mechanisms that differ
in the cells of different age. Indeed, when we transferred cell
culture supernatants from fetal and adult KCs onto fresh
cultures of adult KCs, we could not detect any changes in
AMP expression levels (Supplementary Figure S4 online). This
finding is in line with our previously published secretome
analysis of prenatal and postnatal KCs (Iram et al., 2012),
where we could not detect any differences in the baseline
expression levels of a variety of cytokines and chemokines,
suggesting that AMPs are not indirectly enhanced in fetal KCs
via the production and release of other soluble factors.
Interestingly, the capacity to further increase AMP produc-
tion after stimulation with inflammatory triggers was largely
comparable between prenatal and postnatal KCs. Our in vitro
data of postnatal KCs are in line with previously published
in vivo data, showing that baseline expression of most AMPs is
quite low or even absent in the epidermis, but can be strongly
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Figure 4. JMJD3 knockdown (KD) influences the expression of human b-defensin-3 (HBD-3), S100A7, S100A8 S100A9, and cathelicidin. Fetal, neonatal,
and adult keratinocytes (KCs) cultured under (a, c) proliferating and (b, d) differentiated conditions were investigated for (a, b) JMJD3 and (c, d) EZH2
expression levels using quantitative real-time PCR. Fetal KCs were found to express significantly higher levels of JMJD3 as compared with neonatal and adult KCs
(a, b; Mann–Whitney test, *Po0.05, **Po0.005). The median and individual data points of four to nine different donors per group are shown; each data
point represents the mean of a measurement with three replicates. (e) Western blot analysis showed lower expression of H3K27me3 (tri-methyl-lysine 27 on
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experiments are shown. (f) Small interfering RNA (siRNA)-mediated KD of JMJD3 in fetal KCs resulted in significantly lower expression of JMJD3, HBD-3,
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upregulated after pathogen contact or inflammation (Kim
et al., 2006; Abtin et al., 2008; Gla¨ser et al., 2009). The
high baseline production and upregulation of AMPs in
response to inflammatory stimuli in fetal KCs suggest an
important defense strategy of the skin before birth.
We further present evidence for a methylation-dependent
regulation of at least some AMPs during skin development.
The histone demethylase JMJD3 has been shown to be
involved in epidermal development and antimicrobial
defense, as its expression is required for the transcription of
the KC differentiation locus and the S100A8 gene (Sen et al.,
2008). Transient histone methylation changes that are strongly
tissue- and developmental stage–specific are constantly
ongoing in the fetus, leading to the regulation of multiple
genes (Yuen et al., 2011). Here we could demonstrate that
proliferating and differentiated fetal KCs express significantly
higher JMJD3 mRNA levels than neonatal and adult KCs.
We further identified significant correlations between
the expression of JMJD3 and the AMPs HBD-3, S100A7,
S100A8, and cathelicidin. Moreover, we found that the
trimethylated form of H3K27 was indeed less abundant in
fetal KCs as compared with neonatal and adult KCs. siRNA-
mediated knockdown of JMJD3 confirmed our assumption that
histone methylation is involved in the regulation of AMPs in
fetal KCs. These results show that in addition to S100A8 also
other AMPs are regulated by JMJD3. Whether this is a direct
regulation by demethylation of H3K27m3 in their promoter
regions, as previously shown for S100A8 (Sen et al., 2008), or
indirect via other mechanisms is currently not known. Our
observation of high JMJD3 and low H3K27me3 levels in fetal
KCs are in line with a study describing a similar phenomenon
in healing epidermis (Shaw and Martin, 2009).
In summary, we have shown a quantitative comparison
of several AMPs in prenatal and postnatal KCs. The data
presented expand our understanding of the complex mechan-
isms involved in maintaining the sterility of the amniotic
cavity, and show that fetal KCs possess a high capacity to
produce AMPs, thereby contributing to innate immune
responses of the developing organism.
MATERIALS AND METHODS
Cell culture
KCs prepared from fetal skin (20–23 weeks of estimated gestational
age) were purchased from CellSystems (Troisdorf, Germany) and
Tebu-bio (Offenbach, Germany). KCs prepared from neonatal fore-
skin and adult skin were purchased from Lonza (Basel, Switzerland).
All KCs were cultured in serum-free KC growth medium (KGM;
Lonza), as described previously (Mildner et al., 2006). For stimulation,
third-passage KCs were cultured in 12-well tissue culture plates
(Corning, Corning, NY) and used at a confluence of 60–70%.
Stimulation was performed in KC basal medium (Lonza). For the
analysis of differentiated KCs, cells were kept in culture for 4 days
after reaching 100% confluence.
Reagents used for the treatment of KCs
For in vitro assays, 10 ng ml 1 recombinant IL-1a (R&D Systems,
Minneapolis, MN) and the following TLRLs (InvivoGen, San Diego,
CA) were used: 1mg ml 1 synthetic tripalmitoylated lipopeptide
(Pam3CSK4; TLR1/2L), 108 cells per ml heat-killed Listeria mono-
cytogenes (TLR2L), 25mg ml 1 poly(I:C), a synthetic analog of
double-stranded RNA (TLR3L), 100 ng ml 1 ultrapure lipopolysac-
charide from Escherichia coli K12 (TLR4L), 500 ng ml 1 purified
flagellin from Salmonella typhimurium (TLR5L), 500 ng ml 1 syn-
thetic lipoprotein of Mycoplasma salivarium (FSL1; TLR6/2L),
10mg ml 1 imiquimod (R837; TLR7L), 1mg ml 1 single-stranded
RNA40 (TLR8L), and 2.5mMml 1 ODN2006 (CpG oligonucleotide
type B; (TLR9L)). For certain experiments, supernatants from fetal and
adult KCs were collected after 24 hours of culture, mixed with the
same volume of fresh medium, and transferred onto confluent adult
KCs. After 24 hours, mRNA was prepared and RT-PCR was performed
as described below.
siRNA-mediated JMJD3 knockdown
Third-passage fetal KCs (50–60% confluence) were transfected using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to a published
protocol (Mildner et al., 2010a). A measure of 1 ml of OPTI-MEM
medium (Invitrogen) was mixed with 10ml of Lipofectamine 2000 and
20ml of a 20mM siRNA (Invitrogen) solution or the scrambled control
RNA (Invitrogen) solution. Three different JMJD3 siRNAs were used
(siRNA ID: HSS146206, HSS146208, and HSS177200). After incuba-
tion at room temperature for 30 minutes, the solution was added to
20 ml of KGM (Lonza) and transferred to the KCs. KCs were then
incubated for 48 hours before mRNA was isolated.
RNA isolation, cDNA synthesis, and quantitative real-time PCR
After stimulation for 16 hours, KCs were washed with phosphate-
buffered saline (PBS), and RNA was isolated using the RNeasy 96 Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instruc-
tions. For cDNA synthesis, RNA was reverse-transcribed with the
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA), and real-time
PCR was carried out with LightCycler480 SYBR Green I Master
(Roche Applied Science, Penzberg, Germany) according to the manu-
facturer’s instructions. The primers used are listed in Supplementary
Table S1 online. The relative expression of the target genes was
calculated by comparing with the housekeeping gene b2-microglo-
bulin or keratin 14 (for stimulation experiments in Table 2, as the
expression of b2-microglobulin was modulated by TLR3 stimulation)
using a formula described previously (Pfaffl, 2001). All real-time PCR
experiments were performed at least in triplicate, and the specificity
of the reactions was confirmed by sequencing of the PCR products.
Preparation of 3D SE cultures
In vitro 3D SEs were generated as described previously (Mildner et al.,
2010a). Briefly, a suspension of collagen type I (PureCol; Advanced
Biomatrix, San Diego, CA) containing 1 105 fibroblasts per ml was
poured into cell-culture inserts (3mm pore size; BD Bioscience, Bedford,
MA) and allowed to gel for 2 hours at 37 1C. After equilibration with
KGM for 2 hours, 1.5 106 KCs, in a total volume of 2 ml of KGM,
were placed on the collagen gel. After overnight incubation, the
medium was removed from both the inserts and external wells and
replaced in the external wells only by serum-free KC-defined medium
consisting of KGM but without bovine pituitary extract and supple-
mented with 1.3 mM calcium, 10mg ml 1 transferrin, 50mg ml 1
ascorbic acid, and 0.1% bovine serum albumin (all Supplements
from Sigma-Aldrich, Vienna, Austria). Serum-free KC-defined medium
was changed every second day for 7 days.
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Western blot analysis
For the analysis of protein expression, monolayer cultured KCs or
epidermis taken from SE cultures were lysed in a buffer containing
50 mM Tris (pH 7.4) and 2% SDS. After sonication, insoluble cell
debris was removed by centrifugation, and the protein concentration
was measured by BCA assay (Pierce, Rockford, IL). After denaturing
with 0.1 M DL-dithiothreitol (Sigma-Aldrich), SDS-PAGE was con-
ducted on 8–18% gradient gels (GE Amersham Pharmacia Biotech,
Uppsala, Switzerland). The proteins were then electrotransferred onto
nitrocellulose membranes (Bio-Rad) and immunodetected with the
following primary antibodies: mouse monoclonal anti-S100A7
(5mg ml 1; clone 47C1068; Abcam, Cambridge, UK), mouse mono-
clonal anti-S100A8 (2mg ml 1; clone S13.67; Acris, Hiddenhausen,
Germany), mouse monoclonal anti-S100A9 (1mg ml 1; clone 47-
8D3; Abcam), anti-H3K27me3 (4mg ml 1; clone mAbcam
6002m; Abcam), and mouse monoclonal anti-glyceraldehyde-3-
phosphate dehydrogenase (dilution 1:2,000; Biogenesis, Poole, UK).
Secondary antibody was sheep anti-mouse horseradish peroxidase
(1:10,000; Amersham, Buckinghamshire, UK) and the reaction
products were detected by chemiluminescence with the ImmunStar
Western C Substrate kit (Bio-Rad) according to the manufacturer’s
instructions. The band intensity of four to seven independent experi-
ments was quantified by densitometric analysis using the ImageJ
software (National Institutes of Health, Bethesda, MD).
Immunofluorescence labeling
Five-mm-thin sections of formalin-fixed, paraffin-embedded
SEs were stained by immunofluorescence labeling, as described
previously (Mildner et al., 2010a). Briefly, fixed sections were
deparaffinized, rehydrated, and washed in PBS (2 5 minutes),
incubated with 10% goat serum at room temperature for
30 minutes, and then with primary antibodies overnight at 4 1C (the
same antibodies as described for western blotting were used).
Sections were then washed in PBS (2 5 minutes) and incubated
with goat anti-rabbit Alexa Fluor 488 (Alexa, Eugene, OR). Slides
were washed in PBS (2 5 minutes) and counterstained with Hoechst
to visualize nuclei. Images were recorded using the AX70 microscope
with the imaging software MetaMorph from Olympus (Hamburg,
Germany).
ELISA
After 24 hours of stimulation of KCs, cell culture supernatants were
harvested and KCs were washed with PBS and lysed with 0.1%
IGEPAL lysis buffer at 4 1C for 15 minutes. Supernatants and cell
lysates were stored at  20 1C until further analyses. Concentrations
of HBD-2 in the supernatant and in the cell lysate were determined
by ELISA Development Kit (Immundiagnostik AG, Bensheim, Ger-
many) according to the manufacturer’s instructions. Optical density at
450 nm was measured using a microplate reader (Fluostar Optima;
BMG Labtech, Offenburg, Germany).
Statistical analysis
Statistical analysis was performed using the program GraphPad Prism
version 5 (GraphPad Software, San Diego, CA), and calculations are
based on the means of independent experiments (each individual
experiment with three to four replicates; Figures 1, 2, and 4a, and
Tables 1 and 2) or on the individual values of all experiments (Figures
3a, b and 4). Data are represented as individual values (mean of three
to four replicates per experiment) and the median (Figure 1 and
Figure 4a–d) or as mean and SEM (Figures 2–4f and Supplementary
Figures S1 and S2 online). Statistical significance was calculated using
the Mann–Whitney test (unpaired, nonparametric data; Figures 1 and
4a, b), Wilcoxon’s signed-rank test (paired, nonparametric data,
Tables 1 and 2), unpaired t-test (Figure 2 (comparison of nonstimu-
lated controls) and Figure 3), or paired t-test (Figure 2 (comparison of
stimulations) and Figure 4f). The correlation coefficient R was
calculated by Spearman’s correlation test (nonparametric data;
Supplementary Figure S3 online). A P-value below 0.05 was regarded
as significant and is depicted with *, and a P-value below 0.005 is
depicted with **.
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